These success, along with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two help the strategy of focusing on ACKR3 as a unique method to modulate the opioid program, which could open new therapeutic avenues for opioid-similar disorders.Scientists think that blocking this scaven